STRONG EVIDENCE

Topical Corticosteroids

Also discussed as: topical corticosteroids, topical corticosteroid, topical steroid, topical steroids, steroid cream, steroid creams

Topical corticosteroids are widely recognized as a primary treatment for managing inflammation in atopic dermatitis. While they are effective, there are potential side effects associated with their use that should be considered.

Evidence grade · papers only

STRONG EVIDENCE

21 level-I · 1 level-V · 38 level-II · 17 level-IV · 14 level-VI · 6 level-III · 5 level-VII

Research base (design-resolved): 21 systematic review/meta-analysis, 38 randomized trials, 38 observational/descriptive.

Community interest · posts only

very high · 41,209 mentions

Most discussed for: topical_prescription, topical_otc, oral_medication

What the research says

Topical corticosteroids are the main line of inflammation management in atopic dermatitis.

Radhakrishnan et al. (2024), International Journal of Molecular Sciences. doi:10.3390/ijms25105375 · verified

Topical corticosteroids remain the mainstay in the treatment of atopic dermatitis.

Çetinarslan et al. (2023), Frontiers in Molecular Biosciences. doi:10.3389/fmolb.2023.1159404 · verified

Topical steroids are considered to be easily accessible but can be associated with undesirable side effects. (n=2)

Soares et al. (2023), Journal of Clinical Medicine. doi:10.3390/jcm12103419 · verified

Led to a significant reduction in S-MDA levels after treatment. (n=16336)

Cordiano et al. (2023), Molecules. doi:10.3390/molecules28165979 · verified

Topical corticosteroids remain the gold standard of AD treatment.

Lugović‐Mihić et al. (2023), Life. doi:10.3390/life13061419 · verified

Topical mometasone treatment regulated various immune- and skin barrier-related biomarkers.

Yu et al. (2022), Frontiers in Medicine. doi:10.3389/fmed.2022.1028694 · verified

Topical corticosteroids remain the first-line therapy for atopic dermatitis.

Ma et al. (2022), Frontiers in Cell and Developmental Biology. doi:10.3389/fcell.2022.942838 · verified

What the community reports

Experience reports, not evidence. Volumes from 1.1M triaged posts.

topical_prescription
topical_otc
oral_medication
other
lifestyle_change
traditional_medicine

Safety and side effects

Topical corticosteroids can be associated with side effects such as skin atrophy, skin thinning, and immune suppression. There may also be concerns about skin infections and other long-term side effects.

For infants and children

Topical corticosteroids are approved for use in children and adults, but they are not generally recommended for children under 2 years. Careful monitoring is advised when used in infants and children.

Studied protocols

As reported in the papers, not recommendations.

route: topical

How et al. (2020), Frontiers in Pharmacology

dose: Alclometasone dipropionate (Almeta®), betamethasone valerate (Rinderon®-V), mometasone furoate (Fulumeta®); frequency: twice daily; route: topical; duration: from registration day to 28 weeks of age

Yamamoto‐Hanada et al. (2018), Clinical and Translational Allergy

dose: moderate to high potency; frequency: initial treatment followed by dose reduction; route: topical

Thomas Bieber (2010), Annals of Dermatology

dose: medium-potency; frequency: once daily; route: topical; duration: 16 weeks

Bruin‐Weller et al. (2017), British Journal of Dermatology

dose: 0.1% cream (mometasone furoate); frequency: as needed; route: topical; duration: 16 weeks

Silverberg et al. (2020), British Journal of Dermatology

dose: 0.05% betamethasone dipropionate or 0.05% clobetasol propionate; route: topical

Masutaka Furue (2020), Journal of Clinical Medicine

Drawn from 93 papers · generated 2026-06-11T12:40:16.339700+00:00 · phrasing by gpt-4o-mini, every number computed from the database and every citation machine-verified.